CTOs on the Move

Southwestern Health

www.southwesternhealth.org

 
Southwestern Health Resources, which blends the strengths of University of Texas Southwestern Medical Center and Texas Health Resources, includes a network of 29 hospital locations and more than 5,000 physicians, committed to being the national leader in population health. With more than 500 points of access to care, this provides for higher value and allows patients to access services across a full continuum of medical needs. The network serves people across 17 counties in North Texas. In total, Southwestern Health coordinates care for more than 650,000 patients, aligned with commercial health care plans and Medicare programs. SWHR operates the nation`s ...
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details
Shashi Vangala
Chief Data Analytics and Value Creation Officer Profile
Thomas Marlow
Chief Information Officer Profile

Similar Companies

Sadler Health Center

Sadler Health Center is a federally qualified health center serving Cumberland and Perry counties providing comprehensive community based primary care, dental care and behavioral health services.

MedAccess

MedAccess is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Danville Regional Health System

Danville Regional Health System is a Danville, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Glen Oaks

Glen Oaks is a New London, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Glytec System

Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.